Search results
Nathan Reeves on Food and Drug Administration (FDA) | JD Supra
JD Supra· 10 hours agoThis Privacy Policy describes how JD Supra, LLC ("JD Supra" or "we," "us," or "our") collects, uses and shares personal data collected from visitors to ...
FDA report highlights need to improve diversity in clinical trials
Clinical Trials Arena via Yahoo Finance· 3 hours agoThe US Food and Drug Administration’s (FDA) Center for Drug Evaluation
FDA approves Bristol Myers Squibb’s Breyanzi for follicular lymphoma
Pharmaceutical Technology via Yahoo Finance· 6 hours agoThe US Food and Drug Administration (FDA) has granted accelerated approval for Bristol Myers Squibb...
Axogen begins FDA submission for nerve graft product By Investing.com
Investing.com· 2 hours agoAxogen, Inc. (NASDAQ: AXGN), a company specializing in surgical solutions for peripheral nerve...
Atraverse receives approval for HOTWIRE Left Heart Access Device
Medical Device Network via Yahoo Finance· 5 hours agoAtraverse Medical has received the US Food and Drug Administration (FDA) clearance for its HOTWIRE...
San Diego's Cue Health had the first FDA-approved home COVID-19 test. Now the agency says to throw...
U-T San Diego· 1 day agoThe U.S. Food and Drug Administration told consumers Monday to throw out any at-home COVID-19 tests...
Wondfo USA’s Covid-19/Influenza Test receives FDA EUA approval
Medical Device Network via Yahoo Finance· 6 hours agoA&B Test received emergency use authorisation (EUA) from the US Food and Drug Administration (FDA
Medicare Coverage of Wegovy Raises Questions Regarding the Affordability and Accessibility of Novel...
The National Law Review· 22 hours agoIn Wegovy’s case, the FDA recently approved an additional indication “to reduce the risk of major...
Ventilator recall issued with warning of "serious injuries or death"
Newsweek· 1 day agoThe U.S. Food and Drug Administration (FDA) has ordered a software recall for a type of ventilator...
FDA extends review of Ascendis Pharma's hypoparathyroidism drug By Investing.com
Investing.com· 2 days agoAscendis Pharma A/S (NASDAQ:ASND), a biopharmaceutical company, has received notice from the U.S. ...